Results 201 to 210 of about 53,254,105 (402)

Grey Matter Volume in Substance Use: A Preregistered, Dimensional Approach to Disentangle Substance Use and Disorder Severity. [PDF]

Addict Biol
Schwarz K, Hildebrandt MK, Sauer N, Wüllhorst R, Endrass T.   +4 more
europepmc   +1 more source

Adsorption gas chromatography using water vapor as the carrier gas for organic substances containing oxygen

, 1967
Akira Nonaka
openalex   +2 more sources

The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

Molecular Oncology, EarlyView.
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau, Stephan Forchhammer, Birgit Fehrenbacher, Lejla Mahmutovic, Marcus Scharpf, Gunnar Blumenstock, Martin Schaller, Irina Bonzheim, Shayan Khozooei, Mahmoud Toulany   +9 more
wiley   +1 more source

Dog ownership for people with substance use disorder: self-reported influence on substance use and mental health. [PDF]

Subst Abuse Treat Prev Policy
Kerr-Little A, Bramness JG, Newberry RC, Biong S.   +3 more
europepmc   +1 more source

Studies on Carcinostatic Substances. XL. Application of Cell Counting Method to the Screening of Antitumor Substances using the in vitro-cultured Yoshida Sarcoma Cells.

, 1962
Ayako Moriwaki
openalex   +2 more sources

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

Molecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp, Wouter P. R. Verdurmen, Jonas V. Schaefer, Kari Kopra, Gabriela Nagy‐Davidescu, Elodie Richard, Marie‐Julie Nokin, Patrick Ernst, Rastislav Tamaskovic, Martin Schwill, Ralph Degen, Claudia Scholl, David Santamaria, Andreas Plückthun   +13 more
wiley   +1 more source

Substance use disorders: a call for a staging paradigm. [PDF]

Transl Psychiatry
Bachi K, Hurd YL, Salsitz EA.
europepmc   +1 more source

A New Method for Extraction of Sedimented Humic Substances by Using Elution Column

, 1966
Ryoshi Ishiwatari, Takahisa Hanya
openalex   +2 more sources

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source

Adolescents' experiences with substance use: risks, protective factors and interventions. [PDF]

BMC Psychol
Avcı M.
europepmc   +1 more source